NCT06386497Recruiting
Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease
Overnight Treatment of Parkinson's Disease Using Vestibular Stimulation From a Rocking Bed (Somnomat Casa) - A Feasibility Study
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
This pilot study aims to evaluate the feasibility and acceptability of nocturnal translational vestibular stimulations (VS) applied by a rocking bed (Somnomat Casa) for two months in patients with Parkinson's Disease.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 15 Apr 2024
- Start date
- Jan 2024
- Primary completion date
- Dec 2027
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Diseases
- Parkinson disease
- NCT number
- NCT06386497
What you commit to
- Study type: Interventional
- Planned participants: 15
- From Jan 2024 to the primary completion date, Dec 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Brain disease other than Parkinson's disease (e.g. atypical Parkinsonism, Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy, etc.).
- Dementia as defined by a MOCA score lower than 24/30
- Presence of major ongoing psychiatric illness such as acute non-controlled psychosis
- Poor general health (e.g. non-controlled diabetes, uncontrolled arterial hypertension, therapy for malignancy)
- Inability to follow the procedures of the study, e.g. filling out patient questionnaires due to language problems, psychological disorders, dementia, etc. of the participant
Other
- Weight \> 150kg
- Depression with acute suicidal ideation
- Participation in another interventional trial within the 30 days preceding and during the present study
- Participants with PSQI score lower or equal 5
Who the study is looking for
- Informed Consent signed by the subject
- PD according to the MDS clinical diagnostic criteria for Parkinson's disease
- Suffering from reduced sleep quality as defined by pathological cut-off (score of \> 5) on the Pittsburgh Sleep Quality Index (PSQI)
- Patients with stable antiparkinsonian, antidepressant, and sleep medications for six weeks before intervention and maintained on stable medication during the intervention period
- Treatment without bilateral deep brain stimulation
- Fluent in German
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Insel Gruppe AG University Hospital Bern Coordinator of this site? Confirm its status | Bern | Switzerland | Recruiting |
| ETH Zurich, Sensory-Motor Systems Lab, IRIS Coordinator of this site? Confirm its status | Zurich | Switzerland | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.